𝔖 Bobbio Scriptorium
✦   LIBER   ✦

TULA proteins regulate activity of the protein tyrosine kinase Syk

✍ Scribed by Rachana Agrawal; Nick Carpino; Alexander Tsygankov


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
426 KB
Volume
104
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

TULA belongs to a two‐member family: TULA (STS‐2) is a lymphoid protein, whereas STS‐1/TULA‐2 is expressed ubiquitously. TULA proteins were implicated in the regulation of signaling mediated by protein tyrosine kinases (PTKs). The initial experiments did not fully reveal the molecular mechanism of these effects, but suggested that both TULA proteins act in a similar fashion. It was shown recently that STS‐1/TULA‐2 dephosphorylates PTKs. In this study, we analyzed the effects of TULA proteins on Syk, a PTK playing an important role in lymphoid signaling. First, we have shown that TULA‐2 decreases tyrosine phosphorylation of Syk in vivo and in vitro and that the intact phosphatase domain of TULA‐2 is essential for this effect. We have also shown that TULA‐2 exhibits a certain degree of substrate specificity. Our results also indicate that inactivated TULA‐2 increases tyrosine phosphorylation of Syk in cells co‐transfected to overexpress these proteins, thus acting as a dominant‐negative form that suppresses dephosphorylation of Syk caused by endogenous TULA‐2. Furthermore, we have demonstrated that phosphatase activity of TULA is negligible as compared to that of TULA‐2 and that this finding correlates with an increase in Syk tyrosine phosphorylation in cells overexpressing TULA. This result is consistent with the dominant‐negative effect of inactivated TULA‐2, arguing that TULA acts in this system as a negative regulator of TULA‐2‐dependent dephosphorylation. To summarize, our findings indicate that TULA proteins may exert opposite effects on PTK‐mediated signaling and suggest that a regulatory mechanism based on this feature may exist. J. Cell. Biochem. 104: 953–964, 2008. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Growth-related oncogene produced in huma
✍ Jing Li; Neil Sidell 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 355 KB

Syk, a nonreceptor type of protein tyrosine kinase widely expressed in hematopoietic cells, is a candidate suppressor gene in human breast cancer. Reduced expression of Syk protein is correlated with poor prognosis, while its overexpression can reduce the malignant phenotype of breast cancer cells.

An osteoclastic protein-tyrosine phospha
✍ K.-H. William Lau; Li-Wha Wu; Matilda H.-C. Sheng; Mehran Amoui; Sung Min Suhr; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 2 views

## Abstract This study tested the hypothesis that an osteoclastic protein‐tyrosine phosphatase, PTP‐oc, enhances osteoclast activity through c‐Src activation. The effects of several resorption activators and inhibitors on PTP‐oc expression, resorption activity, and c‐Src activation were determined

Mitogen-activated protein kinase activat
✍ T Adachi; S Nakashima; S Saji; T Nakamura; Y Nozawa 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 1 views

nases. These results suggest that PTK, Ras, and PKC Hepatocyte growth factor (HGF) stimulated mitogenplay roles in MAP kinase activation induced by HGF and activated protein (MAP) kinases and MAP kinase kinase that MAP kinase activation resulting in AA release is in primary cultured rat hepatocytes.